Treatment with canagliflozin may not significantly lower risk for myocardial infarction among patients with type 2 diabetes and comorbid chronic kidney disease or among patients with diabetes who have a history of or have a high risk for CVD.
This nested case-control study included more than 300 patients from the PREVEND study who experienced a first CV event.
To help clinicians and patients determine if antibodies protect against reinfection, the ACP discussed tests for diagnosing and estimating the prevalence of COVID-19.
The safety and efficacy of immune checkpoint inhibition in patients with advanced melanoma with and without autoimmune disease was assessed.
A team of investigators assessed the impact of the consumption of dairy products on the incidence of metabolic syndrome among children and adolescents.
The researchers investigated whether there are associations between different classes of glucose-lowering drugs and risk of COVID-19-related mortality in people with type 2 diabetes.
Liver disease risk for patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis treated with methotrexate were compared.
The European Task Force on Atopic Dermatitis (ETFAD) issues a position on COVID-19 vaccination on adults with atopic dermatitis who are treated with biologic agents and systemic medication.
Hemopexin was an effective biomarker protein capable of diagnosing chronic obstructive pulmonary disease (COPD) and differentiating COPD from asthma.
Researchers examined the association between serum potassium concentration and outcomes in patients with heart failure with preserved ejection fraction.
